Alexion Launches 2020 CSR Report Written From Employee Perspective
Published 5 hours ago
Alexion releases its 2020 CSR report,
Dear Communities, which is written from the first-person perspective of Alexion employees. The report details the company’s performance on broad ESG considerations.
Report Highlights
Alexion, a global biopharmaceutical company (NASDAQ: ALXN), is committed to all the communities we engage with including patients, caregivers and their families; our valued employees and future talent; our neighbors around the world; investors; patient organizations; suppliers; business partners and others. This collective passion comes to life in our 2020 Corporate Social Responsibility (CSR) report,
Dear Communities, which is written from the first-person perspective of Alexion employees.
5 prominent national and global rare disease-focused organizations. Combined, these organizations are
supporting 122,000 rare disease patients and families with Alexion Charitable Foundation’s funding. Ronald McDonald House Charities (RMHC), for example, applied Foundation funding toward a newly launched Global Health and Wellness Initiative in its France, Italy, Australia, and UK chapters. This program helps local families and caregivers cope with their children’s diseases and fosters psychosocial and physical well-being. Another RARE BELONGING grantee, Angel Flight Northeast (AFNE), provides cost-free air and ground transportation and accommodations for patients in need of specialized care outside their immediate area. AFNE Founder and President Rev. Larry Camerlin, shared that the impact is not only quantitative – “it is so amazing how much hope, love, and joy we are bringing to these families with The Alexion Charitable Foundation’s support.”